G2 Investment Partners Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,000
Closed -$354K 90
2022
Q4
$354K Sell
30,000
-5,000
-14% -$57.1K 0.1% 68
2022
Q3
$323K Sell
35,000
-15,000
-30% -$182K 0.1% 75
2022
Q2
$494K Buy
+50,000
New +$1.01M 0.16% 63

Other funds holding ASPN

G2 Investment Partners Management's ASPN Position: Q3 2024 in Review

G2 Investment Partners Management sold out of Aspen Aerogels (ASPN) in Q3 2024, closing a stake of 198,917 shares — an estimated $4.74M sold.

G2 Investment Partners Management first reported a position in ASPN in Q1 2020 and held it in 12 quarters. The position peaked at $20.7M in Q4 2021. 243 funds tracked by Wall St. Rank hold ASPN as of Q3 2024.

  • G2 Investment Partners Management reported no remaining Aspen Aerogels position as of Q3 2024 after selling out during the quarter.
  • G2 Investment Partners Management sold 198,917 Aspen Aerogels shares in Q3 2024, an estimated $4.74M.
  • G2 Investment Partners Management first reported a position in Aspen Aerogels in Q1 2020 and held it in 12 quarters.
  • G2 Investment Partners Management's Aspen Aerogels position peaked at $20.7M in Q4 2021.
  • 243 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2024.

Based on G2 Investment Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.